Unknown

Dataset Information

0

Ibrutinib for the treatment of relapsed/refractory mantle cell lymphoma: extended 3.5-year follow up from a pooled analysis.


ABSTRACT:

SUBMITTER: Rule S 

PROVIDER: S-EPMC6518912 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC4513941 | biostudies-literature
| S-EPMC7686907 | biostudies-literature
| S-EPMC9631700 | biostudies-literature
| S-EPMC8905688 | biostudies-literature
| S-EPMC6853811 | biostudies-literature
| S-EPMC5198949 | biostudies-literature
| S-EPMC3811905 | biostudies-literature
| S-EPMC8518153 | biostudies-literature
| S-EPMC9710495 | biostudies-literature
| S-EPMC8954159 | biostudies-literature